236 related articles for article (PubMed ID: 36916128)
1. PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide.
Al-Zuhairy SAS; Teaima MH; Shoman NA; Elasaly M; El-Nabarawi MA; El-Sawy HS
Drug Deliv; 2023 Dec; 30(1):2189112. PubMed ID: 36916128
[TBL] [Abstract][Full Text] [Related]
2. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
[No Abstract] [Full Text] [Related]
3. P-gp inhibition and enhanced oral bioavailability of amikacin Sulfate: A novel approach using Thiolated Chito-PEGylated Lipidic Hybrids.
El-Say KM; Megahed MA; Abdalla A; El-Sawy HS; Afify H; Ramadan AA; Ahmed TA
Int J Pharm; 2024 Jun; 658():124200. PubMed ID: 38710298
[TBL] [Abstract][Full Text] [Related]
4. Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery.
Sun Y; Li L; Xie H; Wang Y; Gao S; Zhang L; Bo F; Yang S; Feng A
Int J Nanomedicine; 2020; 15():3137-3160. PubMed ID: 32440115
[TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of thermo-responsive nasal in situ gelling system dispersed with piribedil loaded lecithin-chitosan hybrid nanoparticles for improved brain availability.
Uppuluri CT; Ravi PR; Dalvi AV
Neuropharmacology; 2021 Dec; 201():108832. PubMed ID: 34627852
[TBL] [Abstract][Full Text] [Related]
6. Nose-to-brain delivery of octreotide acetate in situ gel for pituitary adenoma: Pharmacological and in vitro cytotoxicity studies.
Gadhave D; Khot S; Tupe S; Shinde M; Tagalpallewar A; Gorain B; Kokare C
Int J Pharm; 2022 Dec; 629():122372. PubMed ID: 36351503
[TBL] [Abstract][Full Text] [Related]
7. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
8. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.
Hard SAAA; Shivakumar HN; Redhwan MAM
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127217. PubMed ID: 37793522
[TBL] [Abstract][Full Text] [Related]
9. Brain targeted delivery of carmustine using chitosan coated nanoparticles via nasal route for glioblastoma treatment.
Ahmad S; Khan I; Pandit J; Emad NA; Bano S; Dar KI; Rizvi MMA; Ansari MD; Aqil M; Sultana Y
Int J Biol Macromol; 2022 Nov; 221():435-445. PubMed ID: 36067850
[TBL] [Abstract][Full Text] [Related]
10. Oleic acid-reinforced PEGylated polymethacrylate transdermal film with enhanced antidyslipidemic activity and bioavailability of atorvastatin: A mechanistic ex-vivo/in-vivo analysis.
El-Say KM; Ahmed TA; Aljefri AH; El-Sawy HS; Fassihi R; Abou-Gharbia M
Int J Pharm; 2021 Oct; 608():121057. PubMed ID: 34461173
[TBL] [Abstract][Full Text] [Related]
11. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
12. Formulation and characterization of lamotrigine nasal insert targeted brain for enhanced epilepsy treatment.
Abdelmonem R; El-Enin HAA; Abdelkader G; Abdel-Hakeem M
Drug Deliv; 2023 Dec; 30(1):2163321. PubMed ID: 36579655
[TBL] [Abstract][Full Text] [Related]
13. Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies.
Elsenosy FM; Abdelbary GA; Elshafeey AH; Elsayed I; Fares AR
Int J Nanomedicine; 2020; 15():9517-9537. PubMed ID: 33324051
[TBL] [Abstract][Full Text] [Related]
14. Design, optimization and pharmacokinetic evaluation of Piribedil loaded solid lipid nanoparticles dispersed in nasal in situ gelling system for effective management of Parkinson's disease.
Uppuluri CT; Ravi PR; Dalvi AV
Int J Pharm; 2021 Sep; 606():120881. PubMed ID: 34273426
[TBL] [Abstract][Full Text] [Related]
15. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
[TBL] [Abstract][Full Text] [Related]
16. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics.
Fatouh AM; Elshafeey AH; Abdelbary A
Drug Des Devel Ther; 2017; 11():1815-1825. PubMed ID: 28684900
[TBL] [Abstract][Full Text] [Related]
17. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation.
Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977
[TBL] [Abstract][Full Text] [Related]
18. AmyloLipid Nanovesicles: A self-assembled lipid-modified starch hybrid system constructed for direct nose-to-brain delivery of curcumin.
Sintov AC
Int J Pharm; 2020 Oct; 588():119725. PubMed ID: 32763387
[TBL] [Abstract][Full Text] [Related]
19. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
[TBL] [Abstract][Full Text] [Related]
20. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
